Survival of Neoadjuvant and Adjuvant Therapy Compared With Surgery Alone for Resectable Esophageal Squamous Cell Carcinoma: A Systemic Review and Network Meta-Analysis

OBJECTIVE: The optimal treatment for resectable esophageal squamous cell carcinoma (ESCC) remains controversial. Surgery is the primary treatment but with poor results. Attempts to improve patient survival have been made by introducing chemotherapy, radiotherapy, or both. However, randomized compari...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Zeliang, Yuan, Meng, Bao, Yongxing, Wang, Yang, Men, Yu, Hui, Zhouguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564474/
https://www.ncbi.nlm.nih.gov/pubmed/34745950
http://dx.doi.org/10.3389/fonc.2021.728185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564474/
https://www.ncbi.nlm.nih.gov/pubmed/34745950
http://dx.doi.org/10.3389/fonc.2021.728185

Ejemplares similares